Compare CLLS & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLLS | AUDC |
|---|---|---|
| Founded | 1999 | 1992 |
| Country | France | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.2M | 267.0M |
| IPO Year | 2014 | 2000 |
| Metric | CLLS | AUDC |
|---|---|---|
| Price | $3.84 | $7.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $12.50 |
| AVG Volume (30 Days) | 31.7K | ★ 221.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.60% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $32.58 | $4.24 |
| Revenue Next Year | $20.68 | $2.18 |
| P/E Ratio | ★ N/A | $23.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | $6.95 |
| 52 Week High | $5.48 | $11.48 |
| Indicator | CLLS | AUDC |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 47.82 |
| Support Level | $3.41 | $7.09 |
| Resistance Level | $4.54 | $9.11 |
| Average True Range (ATR) | 0.18 | 0.29 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 50.00 | 61.86 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.